Literature DB >> 24700679

Genome-wide normalized score: a novel algorithm to detect fetal trisomy 21 during non-invasive prenatal testing.

C H Yeang1, G C Ma, H W Hsu, Y S Lin, S M Chang, P J Cheng, C A Chen, Y H Ni, M Chen.   

Abstract

OBJECTIVES: Non-invasive prenatal testing for fetal trisomy 21 (T21) by massively parallel shotgun sequencing (MPSS) is available for clinical use but its efficacy is limited by several factors, e.g. the proportion of cell-free fetal DNA in maternal plasma and sequencing depth. Existing algorithms discard DNA reads from the chromosomes for which testing is not being performed (i.e. those other than chromosome 21) and are thus more susceptible to diluted fetal DNA and limited sequencing depth. We aimed to describe and evaluate a novel algorithm for aneuploidy detection (genome-wide normalized score (GWNS)), which normalizes read counts by the proportions of DNA fragments from chromosome 21 in normal controls.
METHODS: We assessed the GWNS approach by comparison with two existing algorithms, i.e. Z-score and normalized chromosome value (NCV), using theoretical approximations and computer simulations in a set of 86 cases (64 euploid and 22 T21 cases). We then validated GWNS by studying an expanded set of clinical samples (n = 208). Finally, dilution experiments were undertaken to compare performance of the three algorithms (Z-score, NCV, GWNS) when fetal DNA concentration was low.
RESULTS: At fixed levels of significance and power, GWNS required a smaller fetal DNA proportion and fewer total MPSS reads compared to Z-score or NCV. In dilution experiments, GWNS also outperformed the other two methods by reaching the correct diagnosis with the lowest range of fetal DNA concentrations (GWNS, 3.83-4.75%; Z-score, 4.75-5.22%; NCV, 6.47-8.58%).
CONCLUSION: Our results demonstrate that GWNS is comparable to Z-score and NCV methods regarding the performance of detecting fetal T21. Dilution experiments suggest that GWNS may perform better than the other methods when fetal fraction is low.
Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  MPSS; NIPT; genome-wide; plasma DNA; statistical algorithm

Mesh:

Year:  2014        PMID: 24700679     DOI: 10.1002/uog.13377

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  5 in total

1.  Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management.

Authors:  Baran Bayindir; Luc Dehaspe; Nathalie Brison; Paul Brady; Simon Ardui; Molka Kammoun; Lars Van der Veken; Klaske Lichtenbelt; Kris Van den Bogaert; Jeroen Van Houdt; Hilde Peeters; Hilde Van Esch; Thomy de Ravel; Eric Legius; Koen Devriendt; Joris R Vermeesch
Journal:  Eur J Hum Genet       Date:  2015-01-14       Impact factor: 4.246

Review 2.  Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.

Authors:  Mylène Badeau; Carmen Lindsay; Jonatan Blais; Leon Nshimyumukiza; Yemisi Takwoingi; Sylvie Langlois; France Légaré; Yves Giguère; Alexis F Turgeon; William Witteman; François Rousseau
Journal:  Cochrane Database Syst Rev       Date:  2017-11-10

3.  Performance of the neoBona test: a new paired-end massively parallel shotgun sequencing approach for cell-free DNA-based aneuploidy screening.

Authors:  V Cirigliano; E Ordoñez; L Rueda; A Syngelaki; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2017-02-28       Impact factor: 7.299

4.  Detection of 22q11.2 microduplication by cell-free DNA screening and chromosomal microarray in fetus with multiple anomalies.

Authors:  W-J Wu; G-C Ma; Y-S Lin; C-H Yeang; Y-H Ni; W-C Li; H-D Tsai; S Shur-Fen Gau; M Chen
Journal:  Ultrasound Obstet Gynecol       Date:  2016-09-13       Impact factor: 7.299

5.  Noninvasive prenatal diagnosis of fetal aneuploidy by circulating fetal nucleated red blood cells and extravillous trophoblasts using silicon-based nanostructured microfluidics.

Authors:  Chung-Er Huang; Gwo-Chin Ma; Hei-Jen Jou; Wen-Hsiang Lin; Dong-Jay Lee; Yi-Shing Lin; Norman A Ginsberg; Hsin-Fu Chen; Frank Mau-Chung Chang; Ming Chen
Journal:  Mol Cytogenet       Date:  2017-12-02       Impact factor: 2.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.